Northern Trust Corp Purchases 436,157 Shares of Kenvue Inc. $KVUE

Key Points

• Northern Trust Corp increased its stake in Kenvue Inc. by 2.1% during the 1st quarter, bringing its total ownership to approximately 21.4 million shares worth $512.8 million.
• Several institutional investors, including Price T Rowe Associates and Vanguard Group, also boosted their positions in Kenvue, with 97.64% of the stock currently held by such investors.
• Kenvue recently announced an increase in its quarterly dividend to $0.2075 per share, with a dividend yield of 3.9%, while its earnings per share slightly exceeded analysts' expectations despite a revenue decline.

Northern Trust Corp increased its holdings in shares of Kenvue Inc. (NYSE:KVUE - Free Report) by 2.1% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 21,384,861 shares of the company's stock after purchasing an additional 436,157 shares during the period. Northern Trust Corp owned approximately 1.11% of Kenvue worth $512,809,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in KVUE. NewEdge Advisors LLC lifted its holdings in shares of Kenvue by 14.1% in the fourth quarter. NewEdge Advisors LLC now owns 37,489 shares of the company's stock valued at $800,000 after purchasing an additional 4,637 shares in the last quarter. BI Asset Management Fondsmaeglerselskab A S boosted its position in Kenvue by 45.6% during the 4th quarter. BI Asset Management Fondsmaeglerselskab A S now owns 79,844 shares of the company's stock worth $1,705,000 after acquiring an additional 24,988 shares during the last quarter. Ossiam grew its stake in shares of Kenvue by 20.5% during the 4th quarter. Ossiam now owns 4,709 shares of the company's stock worth $101,000 after acquiring an additional 800 shares in the last quarter. MML Investors Services LLC raised its holdings in shares of Kenvue by 528.3% in the fourth quarter. MML Investors Services LLC now owns 1,125,552 shares of the company's stock valued at $24,031,000 after purchasing an additional 946,422 shares during the last quarter. Finally, Tower Research Capital LLC TRC lifted its position in shares of Kenvue by 53.1% in the fourth quarter. Tower Research Capital LLC TRC now owns 149,644 shares of the company's stock worth $3,195,000 after purchasing an additional 51,903 shares in the last quarter. 97.64% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several brokerages have issued reports on KVUE. Canaccord Genuity Group lowered their price target on shares of Kenvue from $29.00 to $26.00 and set a "buy" rating on the stock in a research note on Friday, August 8th. Bank of America lowered their target price on Kenvue from $27.00 to $25.00 and set a "buy" rating on the stock in a research report on Tuesday, July 15th. Citigroup cut their price target on shares of Kenvue from $24.50 to $22.00 and set a "neutral" rating for the company in a research note on Tuesday, July 15th. Barclays lowered their price objective on shares of Kenvue from $23.00 to $22.00 and set an "equal weight" rating on the stock in a research note on Tuesday, July 15th. Finally, UBS Group reduced their price target on Kenvue from $25.00 to $23.00 and set a "neutral" rating for the company in a report on Thursday, July 17th. Five analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company's stock. According to data from MarketBeat.com, the company currently has an average rating of "Hold" and a consensus target price of $24.38.

Kenvue Stock Performance

Shares of NYSE KVUE traded up $0.1550 during trading hours on Friday, reaching $21.5950. 8,620,226 shares of the stock were exchanged, compared to its average volume of 18,631,350. The firm has a market capitalization of $41.44 billion, a price-to-earnings ratio of 29.18, a P/E/G ratio of 3.10 and a beta of 0.83. The stock's fifty day simple moving average is $21.52 and its 200 day simple moving average is $22.43. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.68 and a current ratio of 0.98. Kenvue Inc. has a 52 week low of $19.75 and a 52 week high of $25.17.

Kenvue (NYSE:KVUE - Get Free Report) last posted its earnings results on Thursday, August 7th. The company reported $0.29 earnings per share for the quarter, topping analysts' consensus estimates of $0.28 by $0.01. The company had revenue of $3.84 billion during the quarter, compared to the consensus estimate of $3.94 billion. Kenvue had a return on equity of 20.06% and a net margin of 9.37%.The company's revenue was down 4.0% on a year-over-year basis. During the same quarter last year, the firm earned $0.32 earnings per share. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. Sell-side analysts predict that Kenvue Inc. will post 1.14 EPS for the current year.

Kenvue Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, August 27th. Investors of record on Wednesday, August 13th will be given a dividend of $0.2075 per share. The ex-dividend date is Wednesday, August 13th. This represents a $0.83 annualized dividend and a yield of 3.8%. This is a boost from Kenvue's previous quarterly dividend of $0.21. Kenvue's dividend payout ratio is 112.16%.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.